ABT · Abbott Laboratories
AI read · Bad for ABT
The AI's read
The claims target a label aimed at shoppers seeking low-sugar drinks. They could weaken trust in Glucerna. The report gives no court ruling or penalty, so the size of any harm is unknown.
Abbott faces claims that Glucerna shakes misstate their sugar content, which could weaken trust in the product. No court ruling or penalty is reported, so the size of any harm is unknown.
The claims target a label aimed at shoppers seeking low-sugar drinks. They could weaken trust in Glucerna. The report gives no court ruling or penalty, so the size of any harm is unknown.
Follow Abbott Laboratories (ABT) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ABT